FC Bayern and Doppelherz have agreed on a multi-year partnership focusing on the international market. The leading European brand for vitamins, minerals and tonics will be the German record champions' new official partner for nutritional supplements. The cooperation is aimed at the European market excluding the German-speaking countries as well as Africa and Asia.
Michael Diederich, deputy CEO of FC Bayern: "Sport and a healthy, balanced, nutrient-rich diet go hand in hand. That's why we’re delighted about the partnership between FC Bayern and Doppelherz. Long-term performance makes all the difference – on the pitch and in everyday life. And athletes, like everyone else, can perform at their best when they have an optimal supply of nutrients."
Tim Simonsen, global head of marketing at Queisser Pharma: "FC Bayern has a unique mentality in German professional sport: consistent pursuit of excellence, maximum demands on its own quality and continuous improvement. We have been constantly improving our products and our portfolio with the same uncompromising attitude for over 100 years."
Erich Nobis, managing director of Queisser Pharma: "Like FC Bayern, our success story is not measured solely by the German market, but also by our international business. The Doppelherz brand already enjoys great trust and holds leading market positions in over 60 international healthcare markets, such as China. A partnership with the internationally successful FC Bayern is therefore only logical. Not only in Europe, but especially in rapidly growing markets such as Asia, the Middle East and Africa, the popularity and trust enjoyed by the FC Bayern brand are ideal attributes for positioning Doppelherz even more strongly. After all, the basis of good health is an active lifestyle, social experiences and the right nutrition."
With its own laboratory, high-quality raw materials and based on the latest findings in nutritional science, Doppelherz pursues the goal of offering products of the highest quality at a very good price-performance ratio.
Topics of this article